These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 6571376

  • 1. [Determination of plasma prolactin in patients with breast dysplasia].
    Vázquez Albaladejo C, Ferrer S, Merle S, Sanchis V, Camps Roig J, Giménez Climent J.
    Rev Esp Oncol; 1983; 30(3):323-36. PubMed ID: 6571376
    [Abstract] [Full Text] [Related]

  • 2. [Significance of proliferative breast lesions around breast cancers].
    Moriya T, Manabe T, Sakurai T, Sakamoto K.
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():42-5. PubMed ID: 7747991
    [Abstract] [Full Text] [Related]

  • 3. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM, Basáñez Amuchastegui A, Jiménez Jiménez E, López de Tejada Cabeza I, Goicoechea García J, Méndez Martín J.
    Rev Quir Esp; 1988 Apr; 15(1):17-21. PubMed ID: 3153353
    [No Abstract] [Full Text] [Related]

  • 4. Mammary cancer risk: circulating TSH and prolactin, fibrocystic breast disease in chronoepidemiologic perspective.
    Tarquini B, Benvenuti M, Legnaioli M, Bazzani M, Cagnoni M, Halberg F.
    Cancer Detect Prev; 1981 Apr; 4(1-4):525-34. PubMed ID: 7349819
    [Abstract] [Full Text] [Related]

  • 5. Atypical apocrine adenosis of the breast: a clinicopathologic study of 37 patients with 8.7-year follow-up.
    Seidman JD, Ashton M, Lefkowitz M.
    Cancer; 1996 Jun 15; 77(12):2529-37. PubMed ID: 8640702
    [Abstract] [Full Text] [Related]

  • 6. Benign breast diseases: risk factor or precancerous state?
    Gerber M.
    Eur J Cancer Prev; 1993 Nov 15; 2 Suppl 3():113-8. PubMed ID: 8298440
    [No Abstract] [Full Text] [Related]

  • 7. [Dynamics of gonadotropins and prolactin in dysplasias and cancer of the breast].
    Korolev VI, Skliar SIu, Ponomarev IN.
    Vrach Delo; 1988 Jan 15; (1):59-61. PubMed ID: 3363942
    [No Abstract] [Full Text] [Related]

  • 8. [Pathology, systematic aspects and classification of benign breast diseases].
    Bässler R, Kind M.
    Gynakologe; 1989 Aug 15; 22(4):216-25. PubMed ID: 2676756
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Serum androgen levels and the menstrual cycle in women with benign or malignant breast disease.
    England PC, Sellwood RA, Knyba RE, Irvine JD.
    Clin Oncol; 1981 Sep 15; 7(3):213-9. PubMed ID: 6211319
    [No Abstract] [Full Text] [Related]

  • 11. [Is fibrocystic disease precancerous?].
    De León Antoni E.
    Bol Asoc Med P R; 1989 Nov 15; 81(11):451-4. PubMed ID: 2690835
    [Abstract] [Full Text] [Related]

  • 12. [The concentrations of prolactin and estrogens in women with fibrocystic changes in the breast].
    Sieja K, Stanosz S.
    Ginekol Pol; 2002 Jul 15; 73(7):594-9. PubMed ID: 12375569
    [Abstract] [Full Text] [Related]

  • 13. Beyond fibrocystic disease. The evolving concept of pre-malignant breast disease.
    Shirley SE.
    West Indian Med J; 1999 Dec 15; 48(4):173-8. PubMed ID: 10639833
    [Abstract] [Full Text] [Related]

  • 14. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
    Lampe JW, Nishino Y, Ray RM, Wu C, Li W, Lin MG, Gao DL, Hu Y, Shannon J, Stalsberg H, Porter PL, Frankenfeld CL, Wähälä K, Thomas DB.
    Cancer Epidemiol Biomarkers Prev; 2007 Dec 15; 16(12):2579-86. PubMed ID: 18086761
    [Abstract] [Full Text] [Related]

  • 15. Circadian variation of serum prolactin and TSH of women in health or with mammary carcinoma, fibroadenoma or fibrocystic mastopathy.
    Tarquini B, Gheri R, Romano S, Costa A, Cagnoni M, Lee JK, Halberg F.
    Int J Chronobiol; 1980 Dec 15; 7(2):101-15. PubMed ID: 7450919
    [Abstract] [Full Text] [Related]

  • 16. Ultradian (12-hr) significant component in serum prolactin of healthy women and patients with fibrocystic mastopathy.
    D'Allesandro B, Esposito V, Lo Iudice G, Cagnoni M, Tarquini B.
    Prog Clin Biol Res; 1987 Dec 15; 227B():281-4. PubMed ID: 3628338
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beta-endorphin, steroids, and prolactin. Immunoassay in breast cysts and blood.
    Schön HJ, Schurz B, Wenzl R, Knogler W, Kubista E.
    Arch Pathol Lab Med; 1993 Mar 15; 117(3):248-53. PubMed ID: 8442670
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W, Buerger H, Schmitz K, Ellis IA, van Diest PJ, Sinn HP, Geradts J, Diallo R, Poremba C, Herbst H.
    J Pathol; 2001 Nov 15; 195(4):415-21. PubMed ID: 11745672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.